Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


Articles published in Curr Opin Rheumatol

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    November 2019

  1. Porphyromonas gingivalis and rheumatoid arthritis: Erratum.
    Curr Opin Rheumatol. 2019;31:697.
    PubMed     Text format    


    October 2019
  2. COUTANT F, Miossec P
    Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages.
    Curr Opin Rheumatol. 2019 Oct 21. doi: 10.1097/BOR.0000000000000664.
    PubMed     Text format     Abstract available


    September 2019
  3. LUCCHESE A
    Periodontal bacteria and the rheumatoid arthritis-related antigen RA-A47: the cross-reactivity potential.
    Curr Opin Rheumatol. 2019;31:542-545.
    PubMed     Text format     Abstract available


    July 2019
  4. PERRICONE C, Ceccarelli F, Matteo S, Di Carlo G, et al
    Porphyromonas gingivalis and rheumatoid arthritis.
    Curr Opin Rheumatol. 2019 Jul 1. doi: 10.1097/BOR.0000000000000638.
    PubMed     Text format     Abstract available


    May 2019
  5. LOWIN T, Schneider M, Pongratz G
    Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol. 2019;31:271-278.
    PubMed     Text format     Abstract available


  6. GEORGE MD, Baker JF
    Perioperative management of immunosuppression in patients with rheumatoid arthritis.
    Curr Opin Rheumatol. 2019;31:300-306.
    PubMed     Text format     Abstract available


    March 2019
  7. DAY AL, Curtis JR
    Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices.
    Curr Opin Rheumatol. 2019 Mar 5. doi: 10.1097/BOR.0000000000000602.
    PubMed     Text format     Abstract available


    February 2019
  8. JANI M, Barton A, Hyrich K
    Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
    Curr Opin Rheumatol. 2019 Feb 14. doi: 10.1097/BOR.0000000000000598.
    PubMed     Text format     Abstract available


  9. VALLERAND IA, Patten SB, Barnabe C
    Depression and the risk of rheumatoid arthritis.
    Curr Opin Rheumatol. 2019 Feb 14. doi: 10.1097/BOR.0000000000000597.
    PubMed     Text format     Abstract available


  10. HSIAO B, Fraenkel L
    Patient preferences for rheumatoid arthritis treatment.
    Curr Opin Rheumatol. 2019 Feb 11. doi: 10.1097/BOR.0000000000000591.
    PubMed     Text format     Abstract available


    April 2018
  11. VAN DE SANDE MGH, van Vollenhoven RF
    Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis.
    Curr Opin Rheumatol. 2018 Apr 24. doi: 10.1097/BOR.0000000000000516.
    PubMed     Text format     Abstract available


    March 2018
  12. SAKKAS LI, Bogdanos DP
    Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Mar 13. doi: 10.1097/BOR.0000000000000503.
    PubMed     Text format     Abstract available


  13. PONTARINI E, Lucchesi D, Bombardieri M
    Current views on the pathogenesis of Sjogren's syndrome.
    Curr Opin Rheumatol. 2018;30:215-221.
    PubMed     Text format     Abstract available


  14. HAMMAKER D, Firestein GS
    Epigenetics of inflammatory arthritis.
    Curr Opin Rheumatol. 2018;30:188-196.
    PubMed     Text format     Abstract available


    February 2018
  15. GILES JT
    Getting personal: towards individualized management of rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Feb 19. doi: 10.1097/BOR.0000000000000499.
    PubMed     Text format    


  16. MAHAJAN TD, Mikuls TR
    Recent advances in the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Feb 15. doi: 10.1097/BOR.0000000000000496.
    PubMed     Text format     Abstract available


  17. BONELLI M, Scheinecker C
    How does abatacept really work in rheumatoid arthritis?
    Curr Opin Rheumatol. 2018 Feb 3. doi: 10.1097/BOR.0000000000000491.
    PubMed     Text format     Abstract available


    January 2018
  18. REGIERER AC, Strangfeld A
    Rheumatoid arthritis treatment in patients with a history of cancer.
    Curr Opin Rheumatol. 2018 Jan 31. doi: 10.1097/BOR.0000000000000492.
    PubMed     Text format     Abstract available


  19. DEN BROEDER AA, van Herwaarden N, van den Bemt BJF
    Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts.
    Curr Opin Rheumatol. 2018 Jan 31. doi: 10.1097/BOR.0000000000000487.
    PubMed     Text format     Abstract available


  20. DIXON WG, Michaud K
    Using technology to support clinical care and research in rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Jan 23. doi: 10.1097/BOR.0000000000000485.
    PubMed     Text format     Abstract available


  21. BERGSTRA SA, Allaart CF
    What is the optimal target for treat-to-target strategies in rheumatoid arthritis?
    Curr Opin Rheumatol. 2018 Jan 19. doi: 10.1097/BOR.0000000000000484.
    PubMed     Text format     Abstract available


  22. SLOWIKOWSKI K, Wei K, Brenner MB, Raychaudhuri S, et al
    Functional genomics of stromal cells in chronic inflammatory diseases.
    Curr Opin Rheumatol. 2018;30:65-71.
    PubMed     Text format     Abstract available


    December 2017
  23. RIDGLEY LA, Anderson AE, Pratt AG
    What are the dominant cytokines in early rheumatoid arthritis?
    Curr Opin Rheumatol. 2017 Dec 4. doi: 10.1097/BOR.0000000000000470.
    PubMed     Text format     Abstract available


    September 2017
  24. DARRAH E, Andrade F
    Rheumatoid arthritis and citrullination.
    Curr Opin Rheumatol. 2017 Sep 21. doi: 10.1097/BOR.0000000000000452.
    PubMed     Text format     Abstract available


    July 2017
  25. BOGDANOS DP, Sakkas LI
    From microbiome to infectome in autoimmunity.
    Curr Opin Rheumatol. 2017;29:369-373.
    PubMed     Text format     Abstract available


  26. RAYCHAUDHURI SK, Raychaudhuri SP
    Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis.
    Curr Opin Rheumatol. 2017;29:311-316.
    PubMed     Text format     Abstract available


  27. TANAY A
    Chikungunya virus and autoimmunity.
    Curr Opin Rheumatol. 2017;29:389-393.
    PubMed     Text format     Abstract available


  28. WANG Z, Chang C, Lu Q
    Epigenetics of CD4+ T cells in autoimmune diseases.
    Curr Opin Rheumatol. 2017;29:361-368.
    PubMed     Text format     Abstract available


    April 2017
  29. BRAGAZZI NL, Watad A, Neumann SG, Simon M, et al
    Vitamin D and rheumatoid arthritis: an ongoing mystery.
    Curr Opin Rheumatol. 2017 Apr 29. doi: 10.1097/BOR.0000000000000397.
    PubMed     Text format     Abstract available


  30. ATZENI F, Masala IF, di Franco M, Sarzi-Puttini P, et al
    Infections in rheumatoid arthritis.
    Curr Opin Rheumatol. 2017 Apr 18. doi: 10.1097/BOR.0000000000000389.
    PubMed     Text format     Abstract available


    March 2017
  31. HSIAO B, Fraenkel L
    Incorporating the patient's perspective in outcomes research.
    Curr Opin Rheumatol. 2017;29:144-149.
    PubMed     Text format     Abstract available


  32. VAN DER WOUDE D, Toes RE
    The contribution of autoantibodies to post-translationally modified proteins to inflammatory arthritis.
    Curr Opin Rheumatol. 2017;29:195-200.
    PubMed     Text format     Abstract available


  33. HAHN M, Frey S, Hueber AJ
    The novel interleukin-1 cytokine family members in inflammatory diseases.
    Curr Opin Rheumatol. 2017;29:208-213.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: